Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lofexidine and Dronabinol for Marijuana Dependence
NCT01020019Phase 3Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Jan 2010
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lofexidine, dronabinol in cannabis use disorder (CUD), sponsored by New York State Psychiatric Institute. Started Jan 2010; status: completed.
02
Drugs
lofexidinedronabinol
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT01020019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01020019.